No Data
No Data
Tango Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Tango Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Analysts Are Bullish on These Healthcare Stocks: Apellis Pharmaceuticals (APLS), Tango Therapeutics (TNGX)
Express News | Tango Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $13 From $16
Tango Therapeutics Price Target Cut to $14.00/Share From $16.00 by Guggenheim
Tango Therapeutics Price Target Cut to $14.00/Share From $16.00 by Guggenheim
Tango Therapeutics Is Maintained at Overweight by Barclays
Tango Therapeutics Is Maintained at Overweight by Barclays
Forecasting The Future: 4 Analyst Projections For Tango Therapeutics
Analysts' ratings for Tango Therapeutics (NASDAQ:TNGX) over the last quarter vary from bullish to bearish, as provided by 4 analysts.The table below provides a snapshot of their recent ratings, showca
No Data